⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for positron emission mammography

Every month we try and update this database with for positron emission mammography cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast CancerNCT00896649
Breast Cancer
questionnaire a...
digital mammogr...
positron emissi...
35 Years - Boston Medical Center
Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast CancerNCT00981812
Breast Cancer
PEM Breast Biop...
25 Years - University of Cincinnati
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast CancerNCT02810873
Breast Carcinom...
Positron Emissi...
Positron Emissi...
Fludeoxyglucose...
Copper Cu 64 TP...
18 Years - Thomas Jefferson University
Staging of Axillary Lymph Nodes Using the PEM Flex Solo II Pet Scanner in Patients With Breast CancerNCT01011946
Breast Cancer
Positron Emissi...
18 Years - 75 YearsUniversity of Chicago
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersNCT02978625
Adenoid Cystic ...
Adnexal Carcino...
Anaplastic Larg...
Anaplastic Larg...
Apocrine Carcin...
Cylindrocarcino...
Digital Papilla...
Endocrine Mucin...
Extramammary Pa...
Extraocular Cut...
Hidradenocarcin...
Keratoacanthoma
Malignant Sweat...
Merkel Cell Car...
Microcystic Adn...
NK-Cell Lymphom...
Papillary Adeno...
Porocarcinoma
Primary Cutaneo...
Recurrent Matur...
Recurrent T-Cel...
Refractory Anap...
Refractory Matu...
Refractory Merk...
Refractory Myco...
Refractory Prim...
Refractory Skin...
Refractory T-Ce...
Sezary Syndrome
Signet Ring Cel...
Skin Basal Cell...
Skin Basosquamo...
Skin Squamous C...
Spiradenocarcin...
Squamoid Eccrin...
Squamous Cell C...
Sweat Gland Car...
Trichilemmal Ca...
Vulvar Squamous...
Biopsy
Biospecimen Col...
Computed Tomogr...
Laboratory Biom...
Nivolumab
Positron Emissi...
Talimogene Lahe...
18 Years - National Cancer Institute (NCI)
Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast CancerNCT00896649
Breast Cancer
questionnaire a...
digital mammogr...
positron emissi...
35 Years - Boston Medical Center
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersNCT02978625
Adenoid Cystic ...
Adnexal Carcino...
Anaplastic Larg...
Anaplastic Larg...
Apocrine Carcin...
Cylindrocarcino...
Digital Papilla...
Endocrine Mucin...
Extramammary Pa...
Extraocular Cut...
Hidradenocarcin...
Keratoacanthoma
Malignant Sweat...
Merkel Cell Car...
Microcystic Adn...
NK-Cell Lymphom...
Papillary Adeno...
Porocarcinoma
Primary Cutaneo...
Recurrent Matur...
Recurrent T-Cel...
Refractory Anap...
Refractory Matu...
Refractory Merk...
Refractory Myco...
Refractory Prim...
Refractory Skin...
Refractory T-Ce...
Sezary Syndrome
Signet Ring Cel...
Skin Basal Cell...
Skin Basosquamo...
Skin Squamous C...
Spiradenocarcin...
Squamoid Eccrin...
Squamous Cell C...
Sweat Gland Car...
Trichilemmal Ca...
Vulvar Squamous...
Biopsy
Biospecimen Col...
Computed Tomogr...
Laboratory Biom...
Nivolumab
Positron Emissi...
Talimogene Lahe...
18 Years - National Cancer Institute (NCI)
Positron Emission Tomography in Patients With Breast CancerNCT00001385
Breast Neoplasm...
- National Institutes of Health Clinical Center (CC)
Staging of Axillary Lymph Nodes Using the PEM Flex Solo II Pet Scanner in Patients With Breast CancerNCT01011946
Breast Cancer
Positron Emissi...
18 Years - 75 YearsUniversity of Chicago
Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission MammographyNCT03266562
Breast Neoplasm
F-18 FES
F-18 FDG
40 Years - 90 YearsMayo Clinic
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: